Combination of Remdesivir and Antibodies Didn’t Work Against COVID-19: Study

Contact Your Elected Officials
The Epoch Times Header

A combination of remdesivir and a concentrated solution of antibodies did not work well in people hospitalized with COVID-19, according to a newly published study.

The clinical trial tested remdesivir, an antiviral from Gilead Sciences, combined with anti-coronavirus hyperimmune intravenous immunoglobulin (hIVIG), the concentrated solution, but the combination did not significantly improve favorable outcomes among the patients, researchers reported in The Lancet.

The antibody solution was made using antibodies from blood plasma donated by people who recovered from COVID-19, the CCP (Chinese Communist Party) virus.

About 600 patients spread across Africa, Asia, Europe, North America, and South America were divided into two cohorts for the study. About half received the experimental drug combination while the other half received a placebo and remdesivir.

When measuring the outcomes among the patients after seven days following the treatment, there was little difference between the groups.

Researchers reported that “there was no evidence that patients who received a single infusion of hIVIG in addition to remdesivir and other standard of care had better clinical outcomes at day 7 after randomization than patients who received placebo plus remdesivir and standard of care.”

The hope was when starting the trial that giving people hIVIG at the onset of COVID-19 symptoms could bolster the body’s natural immune response, leading to a reduction of serious illness and death.

The phase 3 trial that researchers reported the results of was funded by the National Institute of Allergy and Infectious Diseases, a U.S. institute directed by Dr. Anthony Fauci.

“Unfortunately, the trial demonstrated that this strategy did not improve the health of adults hospitalized with COVID-19 and may be harmful for a certain subset of patients. Studies testing this strategy in non-hospitalized adults earlier in the course of infection are underway,” Fauci said in a statement.

Studies testing the same combination in adults who have COVID-19 but are not hospitalized are underway.

Remdesivir is one of the most-recommended COVID-19 treatments by the COVID-19 Treatment Guidelines Panel, a panel convened by National Institutes of Health (NIH). Fauci’s institute is part of the NIH. Remdesivir was recently cleared by U.S. drug regulators for use outside hospitals.

The panel said in a recent statement that remdesivir “is expected to be active against” Omicron, a variant of the CCP virus. Gilead said recently that its drug retained activity against Omicron in laboratory testing. U.S. regulators have effectively banned use of two monoclonal antibodies after several preprint studies found lower or little effectiveness against Omicron, which is dominant in the United States.

Remdesivir has drawn criticism from some experts because of its cost and studies indicating it has little to no effect on COVID-19, though other research has suggested it does help COVID-19 patients, at least in some settings. The drug also has serious side effects including kidney failure. The World Health Organization currently recommends against its use in hospitalized patients.

By Zachary Stieber

Read Original Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

A Few Fun Alternatives to the”Gory Stuff” at Halloween

Halloween has gone off the rails with gore through the decades.  But there are ways to enjoy the "scary stuff" without giving into darker, pagan alliances.  

Germany Stands To Lose & Poland To Gain From The EU’s Latest Energy Move

The US is geostrategically re-engineering Europe at Germany’s expense in order to facilitate Russia’s post-Ukraine containment.

EBT Serfs Threaten Violent Mass-Shoplifting Spree if Food Stamps Cut

The EBT serfs of the underclass may be in for a rough ride come November, when mommy government is slated to wean them off the teat of state.

The Real Reason Why the Left is Unhinged

Nine out of thirteen of the original states required you to be a Bible believing Christian to serve in government at the time of the founding.

The Sacrificial Lambs of the Riyadh Standup Scene

Which is the greater injustice: jailing political dissidents, or millions dead from pharma crimes with no accountability for those responsible?

No Shutdown Meeting Until Stopgap Funding Approved, Trump Tells Democrats

Democrats are demanding Republicans renew Affordable Care Act subsidies in exchange for approving the House Appropriations bill.

Texas Appoints Higher Education Ombudsman to Enforce DEI Violations

Texas is moving to enforce bans on DEI practices in universities and potentially restrict college courses focused on gender and race.

House Judiciary Chair Refers Ex-CIA Director John Brennan for Criminal Prosecution

House Republicans referred ex-CIA Director John Brennan to AG Pam Bondi for prosecution over the 2016 probe into alleged Russian–Trump collusion.

FBI Has Arrested 28,000 Violent Criminals Since Jan. 20: Trump

President Trump praised the FBI for doing an “incredible job,” citing thousands of arrests and major disruptions of criminal activity nationwide.

Trump Calls off Meeting With Putin, White House Says

White House says Secretary Rubio and Russia’s Lavrov had a productive call; no further meetings or Trump-Putin talks are planned soon.

President Signs Rare Earth Agreement With Australia’s PM

President Trump hosted Australian PM Albanese at the White House, where both leaders signed a new agreement on rare earth mineral cooperation.

Trump Says Insurrection Act Is ‘Strongest Power a President Has’

President Trump detailed plans to invoke the Insurrection Act to address rampant crime, calling it the “strongest power a president has.”

Army Corps of Engineers to Pause $11 Billion in Projects During Shutdown: Vought

Russ Vought, director of the White House’s OMB, has added to the growing pile of federal projects paused during the government shutdown.
spot_img

Related Articles

Popular Categories

MAGA Business Central